Topical dura mater application of CFA induces enhanced expression of c-fos and glutamate in rat trigeminal nucleus caudalis: attenuated by KYNA derivate (SZR72)

Altered serum levels of kynurenine metabolites in patients affected by cluster headache

(2016) Martina Curto et al.   JOURNAL OF HEADACHE AND PAIN

KYNA analogue SZR72 modifies CFA-induced dural inflammation- regarding expression of pERK1/2 and IL-1β in the rat trigeminal ganglion

(2016) M. Lukács et al.   JOURNAL OF HEADACHE AND PAIN

Altered kynurenine pathway metabolites in serum of chronic migraine patients

(2016) Martina Curto et al.   JOURNAL OF HEADACHE AND PAIN

Release of PACAP-38 in episodic cluster headache patients – an exploratory study

(2016) Bernadett Tuka et al.   JOURNAL OF HEADACHE AND PAIN

Fathoming the kynurenine pathway in migraine: why understanding the enzymatic cascades is still critically important

(2015) Martina Curto et al.   Internal and Emergency Medicine

Headache disorders are third cause of disability worldwide

(2015) Timothy J. Steiner et al.   JOURNAL OF HEADACHE AND PAIN

Dural administration of inflammatory soup or Complete Freund’s Adjuvant induces activation and inflammatory response in the rat trigeminal ganglion

(2015) M. Lukács et al.   JOURNAL OF HEADACHE AND PAIN

Kynurenic acid modulates experimentally induced inflammation in the trigeminal ganglion

(2015) A. Csáti et al.   JOURNAL OF HEADACHE AND PAIN

Pre-treatment with new kynurenic acid amide dose-dependently prevents the nitroglycerine-induced neuronal activation and sensitization in cervical part of trigemino-cervical complex

(2014) Annamária Fejes-Szabó et al.   JOURNAL OF NEURAL TRANSMISSION

Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients

(2013) Bernadett Tuka et al.   CEPHALALGIA

CGRP and migraine: Could PACAP play a role too?

(2013) Eric A. Kaiser et al.   NEUROPEPTIDES

Migraine pathophysiology: Anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain

(2013) Rodrigo Noseda et al.   PAIN

Evidence for Glutamate as a Neuroglial Transmitter within Sensory Ganglia

(2013) Ling-Hsuan Kung et al.   PLoS One

Kynurenines in the CNS: recent advances and new questions

(2012) László Vécsei et al.   NATURE REVIEWS DRUG DISCOVERY

Tracing neural connections to pain pathways with relevance to primary headaches

(2011) Lars Edvinsson   CEPHALALGIA

Headache and prolonged dilatation of the middle meningeal artery by PACAP38 in healthy volunteers

(2011) Faisal Mohammad Amin et al.   CEPHALALGIA

Modifications on the carboxylic function of kynurenic acid

(2011) Ferenc Fülöp et al.   JOURNAL OF NEURAL TRANSMISSION

Kynurenines and intestinal neurotransmission: the role of N-methyl-d-aspartate receptors

(2011) József Kaszaki et al.   JOURNAL OF NEURAL TRANSMISSION

Chronic Migraine: Epidemiology and Disease Burden

(2010) Aubrey N. Manack et al.   Current Pain and Headache Reports

Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion

(2010) S. Eftekhari et al.   NEUROSCIENCE

Brainstem and Thalamic Projections from a Craniovascular Sensory Nervous Centre in the Rostral Cervical Spinal Dorsal Horn of Rats

(2009) Y Liu et al.   CEPHALALGIA

The role of kynurenines in disorders of the central nervous system: Possibilities for neuroprotection

(2009) Eniko Vamos et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Kynurenic acid attenuates MPP+-induced dopaminergic neuronal cell death via a Bax-mediated mitochondrial pathway

(2008) Do Yeon Lee et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

Defining a Pathway to Discovery from Bench to Bedside: The Trigeminovascular System and Sensitization

(2008) Michael A. Moskowitz   HEADACHE

The Janus-face kynurenic acid

(2008) Éva Rózsa et al.   JOURNAL OF NEURAL TRANSMISSION